Author(s):
Year:
- Solutions
- Software
- Featured software:
- Software by solutionRegulatory Discovery Preclinical Early Clinical Late Clinical Market Access & Commercial View software
- Services
- Services by solutionRegulatory Discovery Preclinical Early Clinical Late Clinical Market Access & Commercial View services
- Customers
- Resources
- Featured resources:
- Resources by solutionRegulatory Discovery Preclinical Early Clinical Late Clinical Market Access & Commercial View all resources
- Company
search
Home / Publication / Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases
Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain Metastases
Newsletter sign up
Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.
Solutions
© 2025 Certara. All Rights Reserved. | Privacy policy